Yes, TJW you are probably right, it may have been more a Sankyo decision, as I believe this Product CS 8958 was orginally in Sankyo,s pipeline and Biota,s Flunet were being kept as follow-up lines.
Yes, there are a lot of things GSK could have done, with Relenza and didn,t.................I don,t think if Bird Flu had not come around and the US and WHO had not been pushing things along they wouldn,t have even responded. Very sad for Relenza and I know you are not happy about it.
If there wasn,t any Relenza, there wouldn,t have been any LANI.
Cheers dma
- Forums
- ASX - By Stock
- BTA
- research data sankyo tjw
research data sankyo tjw, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online